Related Experiment Video
Updated: Oct 22, 2025

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
Is the high-dose influenza vaccine better for people over age 65 years?
1Anna Haley is a doctor of pharmacy student at the University of the Sciences, Philadelphia College of Pharmacy, in Philadelphia, Pa. Eric Urnoski is a clinical pharmacy specialist in critical care at Crozer-Chester Medical Center in Upland, Pa. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
Influenza vaccinations are one of the largest public health initiatives each year. The vaccine's components are varied, and the high-dose influenza vaccine was designed to provide better protection for older adults. Patients may request the high-dose vaccine due to a perceived superior benefit. This article describes the vaccine formulations and whether older adults require high-dose compared with standard-dose vaccinations.
More Related Videos
Related Concept Videos
Vaccinations
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

